Reducing Albumin Improves Kidney and Heart Function Reducing Albumin Improves Kidney and Heart Function
The tablet drug finerenone significantly reduces kidney risk in people with type 2 diabetes and also protects heart health, researchers found.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - December 4, 2023 Category: Cardiology Tags: Family Medicine/Primary Care News Source Type: news
Have Type 2 diabetes? New study suggests to walk faster
A new study has indicated that walking at four or more kilometres per hour is associated with a significantly lower risk of type 2 diabetes. (Source: The Economic Times)
Source: The Economic Times - December 4, 2023 Category: Consumer Health News Source Type: news
I reversed my type 2 diabetes. Here ’s how I did it | Neil Barsky
Modern medicine makes it seem as if drugs are the only way to deal with diabetes. But what if diet can be a solution?One gray Sunday in the middle of the Covid lockdown, I received an unwelcome call from my family doctor. Until then, for virtually my entire life, I had managed to stay out of a doctor ’s office, except for routine checkups. My luck had run out.“I am sorry to disturb you on a weekend,” she said. “But your tests just came back and your blood sugar levels are alarming. I am pretty sure you have diabetes.”Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - December 4, 2023 Category: Science Authors: Neil Barsky Tags: Science Health Diabetes Medicine Pharmaceuticals industry Society Source Type: news
Roche enters into a definitive merger agreement to acquire Carmot Therapeutics, including three clinical stage assets with best-in-class potential in obesity and diabetes
Carmot Therapeutics ’s R&D portfolio of clinical stage incretins has great potential to treat obesity, diabetes and potentially other diseases both as standalone medicines and in combination with Roche ’s in-house assetsLead asset CT-388 is a Phase-2 ready dual GLP-1/GIP agonist with best-in-class potential for the treatment of obesity and its comorbiditiesUnder the terms of the agreement, Roche will pay a purchase price of USD 2.7 billion upfront and additional milestone payments of up to USD 400 millionBasel, 4 December 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the entry into a definitive merger a...
Source: Roche Investor Update - December 4, 2023 Category: Pharmaceuticals Source Type: news
Roche enters into a definitive merger agreement to acquire Carmot Therapeutics, including three clinical stage assets with best-in-class potential in obesity and diabetes
Carmot Therapeutics ’s R&D portfolio of clinical stage incretins has great potential to treat obesity, diabetes and potentially other diseases both as standalone medicines and in combination with Roche ’s in-house assetsLead asset CT-388 is a Phase-2 ready dual GLP-1/GIP agonist with best-in-class potential for the treatment of obesity and its comorbiditiesUnder the terms of the agreement, Roche will pay a purchase price of USD 2.7 billion upfront and additional milestone payments of up to USD 400 millionBasel, 4 December 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the entry into a definitive merger a...
Source: Roche Media News - December 4, 2023 Category: Pharmaceuticals Source Type: news
Pfizer announces topline Phase 2b results of oral GLP-1R agonist, danuglipron, in adults with obesity
Pfizer Inc. (NYSE: PFE) announced topline data from the Phase 2b clinical trial (NCT04707313) investigating its oral Glucagon-like peptide-1 receptor agonist (GLP-1RA) candidate, danuglipron (PF-06882961), in adults with obesity and without type 2 diabetes. The study met its primary endpoint demonstrating statistically significant change in body weight from baseline. (Source: World Pharma News)
Source: World Pharma News - December 4, 2023 Category: Pharmaceuticals Tags: Featured Pfizer Business and Industry Source Type: news
'Alexa, Titrate My Insulin': AI App Boosts Glycemic Control in Randomized Trial
(MedPage Today) -- A custom artificial intelligence (AI) app for insulin management advice helped patients with type 2 diabetes gain rapid glycemic control, a small randomized clinical trial found.
In titrating basal insulin, those who used a... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - December 1, 2023 Category: Urology & Nephrology Source Type: news
AI Aids Type 2 Diabetes Insulin Dosing AI Aids Type 2 Diabetes Insulin Dosing
A patient-facing voice-based conversational artificial intelligence application helped patients with type 2 diabetes optimize their insulin doses.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - December 1, 2023 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
High Systolic BP Tied to Higher Cardiovascular Mortality in T2DM
FRIDAY, Dec. 1, 2023 -- Clinic systolic blood pressure (BP)≥130 mm Hg or diastolic BP levels≥90 mm Hg are associated with a higher risk for cardiovascular disease (CVD) mortality in people with type 2 diabetes mellitus (T2DM),... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 1, 2023 Category: Pharmaceuticals Source Type: news
Diabetes Tied to Identifiable Vocal Changes
FRIDAY, Dec. 1, 2023 -- Vocal changes appear to occur in individuals with type 2 diabetes mellitus (T2DM) versus those without diabetes, according to a study published online in the December issue of Mayo Clinic Proceedings: Digital... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 1, 2023 Category: Pharmaceuticals Source Type: news
More proof that not ALL ultra-processed foods are bad? Only meats like bacon, pizza, noodles and ice cream raise risk of type 2 diabetes, study claims
Researchers in South Korea, who explored risk factors for getting type 2 diabetes, said only the likes of pizza, noodles, ice cream, sausage and ham actually raise the risk of getting the condition. (Source: the Mail online | Health)
Source: the Mail online | Health - December 1, 2023 Category: Consumer Health News Source Type: news
Why ‘ Healthspan ’ May Be More Important Than Lifespan
In 2014, then-57-year-old bioethicist Dr. Ezekiel Emanuel wrote an infamous essay titled, “Why I Hope to Die at 75” for The Atlantic. His argument boiled down to this: it’s not worth living as long as humanly possible if those efforts yield extra decades defined by disease and poor health, which data suggest is the fate awaiting many people in the U.S.
Nearly a decade later, neither Emanuel’s mind nor the statistics have changed much. Emanuel still says he plans to stop most life-extending medical care once he reaches age 75, though he’s healthy enough that he expects to live longer natural...
Source: TIME: Health - November 30, 2023 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthscienceclimate Source Type: news
Walking at Faster Speeds Linked to Reduction in Risk for Type 2 Diabetes
WEDNESDAY, Nov. 29, 2023 -- Walking at faster speeds seems to be associated with a reduction in the risk for type 2 diabetes, according to a review published online Nov. 28 in the British Journal of Sports Medicine.Ahmad Jayedi, Ph.D., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 29, 2023 Category: Pharmaceuticals Source Type: news
Your Walking Speed Influences Your Risk for Diabetes
WEDNESDAY, Nov. 29, 2023 -- People can walk away their risk of developing type 2 diabetes – but only if they walk fast enough, a new report finds.Folks who walk at least 2.5 miles an hour appear to have a significantly lower risk of type 2... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 29, 2023 Category: General Medicine Source Type: news
Want to reduce your risk of type 2 diabetes? Try walking faster: Study claims picking up the pace to 3.7mph slashes odds by over a third
An international team of researchers, including from Imperial College London , wanted to ascertain the optimal walking speed to stave off the condition. (Source: the Mail online | Health)
Source: the Mail online | Health - November 29, 2023 Category: Consumer Health News Source Type: news
